Genmab
Genmab is a global biotechnology company dedicated to developing innovative antibody medicines to improve patients' lives. They focus on creating therapies for serious diseases such as cancer, emphasizing compassion, scientific innovation, and collaboration across their teams.
Headquarters
Valby, Hovedstaden, Denmark
Company Size
1001-5000 employees
Founded
1999
Genmab is an international biotech company specializing in antibody therapeutics for the treatment of cancer and other serious diseases
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Genmab.
Genmab didn’t post a salary, so this is our estimate from similar listings.
Right around the average for this role
Genmab Updates Share Buy-Back Program and Corrects Accumulated Purchase Figures
3 days ago
Medical Director, Clinical Development
Zymeworks
Senior Manager or Manager, Medical Affairs Strategy Scientist
talisman corporation
Director, Global Value & Access Strategy, povetacicept
Vertex
Director, Regulatory Affairs Strategy
Arcellx
Senior Clinical Trial Manager (Sr CTM)
Corcept Therapeutics
Director of Clinical Science - Hematology
Systimmune